PALISADE BIO, INC. Shares Issued
PALISADE BIO, INC. (PALI) had Shares Issued of 173.60 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-10
- 2026-06-30: Common Stock, Shares, Issued 173.60M shares.
- 2026-03-31: Common Stock, Shares, Issued 167.42M shares.
- 2025-12-31: Common Stock, Shares, Issued 159.44M shares.
- 2025-09-30: Common Stock, Shares, Issued 9.12M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 173.60M shares 10-Q · filed 2026-08-10 | |
| 2026-03-31 | 167.42M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 159.44M shares 10-Q · filed 2026-08-10 | |
| 2025-09-30 | 9.12M shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 4.80M shares 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 4.40M shares 10-Q · filed 2025-05-12 | |
| 2024-12-31 | 2.77M shares 10-K · filed 2026-03-20 | |
| 2024-09-30 | 1.20M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 966.35K shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 851.30K shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 618.06K shares 10-K · filed 2025-03-24 | 9.27M shares 10-K · filed 2024-03-26 |
| 2023-09-30 | 9.21M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 6.85M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 4.56M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 2.94M shares 10-K · filed 2024-03-26 | |
| 2022-09-30 | 77.08M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 21.88M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 18.23M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 284.78K shares 10-K · filed 2023-03-22 | 14.24M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 12.93M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 11.40M shares 10-Q · filed 2021-08-23 | |
| 2021-03-31 | 2.88M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 2.77M shares 10-K · filed 2022-03-17 | 17.30M shares 10-K · filed 2021-03-22 |
| 2020-09-30 | 17.30M shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 17.30M shares 10-Q · filed 2020-08-13 | |
| 2020-03-31 | 9.43M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 3.87M shares 10-K · filed 2021-03-22 | |
| 2019-09-30 | 2.82M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 1.00M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 18.21M shares 10-Q · filed 2019-05-14 | |
| 2018-12-31 | 910.25K shares 10-K · filed 2020-03-27 | 18.21M shares 10-K · filed 2019-03-22 |
| 2018-09-30 | 15.21M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 15.16M shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 15.16M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 15.16M shares 10-K · filed 2019-03-22 | |
| 2017-09-30 | 15.15M shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 12.01M shares 10-Q · filed 2017-08-08 | |
| 2016-12-31 | 11.03M shares 10-K · filed 2018-04-02 | |
| 2016-09-30 | 114.82M shares 10-Q · filed 2016-11-08 | |
| 2016-06-30 | 114.76M shares 10-Q · filed 2016-08-11 | |
| 2016-03-31 | 92.04M shares 10-Q · filed 2016-05-09 | |
| 2015-12-31 | 7.08M shares 10-K · filed 2017-03-23 | 92.01M shares 10-K · filed 2016-03-14 |
| 2014-12-31 | 87.79M shares 10-K · filed 2016-03-14 | |
| 2013-12-31 | 77.89M shares 10-K · filed 2015-03-16 | |
| 2012-12-31 | 68.19M shares 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |